IMARC Group’s report “PET-CT Scanner Devices Market Report: By Type (Stationary Scanners, Portable/Mobile Scanners), By Number of Slices (Low-Slice Scanners (< 64 Slices), Medium Slice Scanners (64 Slices), High-Slice Scanners (> 64 Slices)), by Isotope and Detector Type (Fluorodeoxyglucose (FDG), 62Cu ATSM, 18F Sodium Fluoride, FMISO, Gallium, Thallium, and Others), by Service Provider (Hospitals, Diagnostic Centers, Research Institutes), Application (Oncology, Neurology, Cardiology, and Others), and by Region 2024-2032The global PET-CT scanner device market size reached USD 2.2 billion in 2023. Looking ahead, IMARC Group forecasts that it will reach US$ 3.1 Billion by 2032, exhibiting a growth rate (CAGR) of 3.62% during 2024-2032.
Get a Mr./Ms. pull PDF of this report: https://www.imarcgroup.com/pet-ct-scanner-device-market/requestsample
Global PET-CT Scanner Equipment Market Trends
The shift towards personalized medicine is driving the demand for PET-CT scanners. Personalized medicine aims to tailor treatment plans to individual patients based on their specific genetic makeup and disease characteristics. PET-CT scanners play a crucial role in this paradigm by providing detailed images that help in understanding the molecular and functional aspects of diseases. This precision in imaging allows for more accurate diagnosis, treatment planning, and monitoring, particularly in oncology, where understanding tumor behavior at a molecular level is essential. The increasing focus on personalized medicine is encouraging healthcare providers to adopt PET-CT scanners. As personalized medicine continues to evolve, the demand for advanced imaging technologies like PET-CT is expected to rise correspondingly.
Factors influencing the growth of the PET-CT scanner devices industry:
- Advancements in Medical Imaging Technology:
Continuous advancements in medical imaging technology are impelling the market growth. The integration of positron emission tomography (PET) and computed tomography (CT) into a single device enhances diagnostic accuracy and patient care. Innovations, such as higher resolution imaging, faster scan times, and improved image reconstruction algorithms, have elevated the capabilities of PET-CT scanners, making them indispensable in detecting and monitoring various diseases, particularly cancer. Additionally, the development of hybrid imaging systems that combine PET-CT with other modalities like MRI further expands diagnostic potential, attracting substantial investment and adoption in healthcare facilities globally. These technological advancements not only improve patient outcomes but also streamline clinical workflows, making the adoption of PET-CT scanners more appealing to healthcare providers.
- Rising Prevalence of Chronic Diseases:
The increasing prevalence of chronic diseases, especially cancer and cardiovascular diseases, is a major factor driving the demand for PET-CT scanners. These conditions require accurate and early diagnosis to manage and treat effectively, and PET-CT scanners are pivotal in this regard. The aging global population contributes significantly to this trend, as older individuals are more susceptible to chronic ailments. PET-CT scanners provide comprehensive imaging that aids in staging cancer, monitoring treatment response, and detecting metastasis, thereby playing a crucial role in the management of chronic diseases. The growing awareness about the importance of early diagnosis and the subsequent increase in screening programs also drive the utilization of PET-CT scanners.
- Government Initiatives and Healthcare Expenditure:
Government initiatives and increasing healthcare expenditure are supporting the market growth. Many governments worldwide are investing in healthcare infrastructure, aiming to provide advanced diagnostic tools and improve public health outcomes. Funding for research and development, along with subsidies and incentives for healthcare providers to adopt cutting-edge technologies, is driving the adoption of PET-CT scanners. Additionally, favorable reimbursement policies for diagnostic imaging procedures make these advanced technologies more accessible to patients, encouraging healthcare providers to invest in PET-CT scanners. This support from governmental bodies not only accelerates technological adoption but also ensures that more healthcare facilities can offer sophisticated imaging services.
Leading companies operating in the global PET-CT Scanner Equipment industry:
- Bruker Corporation
- Canon Medical Systems USA, Inc.
- General Electric Company
- Hitachi, Ltd.
- Koninklijke Philips N.V.
- Mediso Inc.
- New Soft Inc.
- Positron Corporation
- Shimadzu Corporation
- Siemens Healthcare GmbH (Siemens AG)
- Sophie Biosciences K.K.
- United Imaging Healthcare, Inc.
- Yangzhou Kindsway Biotechnology Co., Ltd.
View the full report, including table of contents: https://www.imarcgroup.com/pet-ct-scanner-device-market
PET-CT Scanner Devices Market Report Segmentation:
By Type:
- Stationary scanner
- Portable Scanners/Mobile Scanners
Stationary scanners account for the largest segment due to their high image quality, reliability, and suitability for a wide range of clinical applications.
By number of slices:
- Low-slice scanner (<64-slice)
- Medium Slice Scanner (64 Slices)
- High-Slice Scanner (> 64-slice)
Medium-slice scanners (64 slices) account for the majority of the market share due to their balance between image resolution and cost-effectiveness, making them a popular choice among healthcare professionals.
By Isotope and Detector Type:
- Flurodeoxyglucose (FDG)
- 62Cu ATSM
- 18 F Sodium Fluoride
- FMISO
- gallium
- thallium
- others
Flurodeoxyglucose (FDG) shows a distinct advantage in the market due to its widespread availability, well-established efficacy in cancer imaging, and reimbursement support.
By Service Provider:
- hospital
- Diagnostic Centers
- Research Institutes
Hospitals account for the largest market share by driving comprehensive diagnostic and treatment services, including PET-CT imaging, to a wide patient population.
By Application:
- oncology
- neurology
- cardiology
- others
Oncology dominates the market, which can be attributed to the utilization of PET-CT images in cancer diagnosis, staging, treatment planning, and response assessment.
Regional Insights:
- North America (United States, Canada)
- Asia Pacific (China, Japan, India, Korea, Australia, Indonesia, Others)
- Europe (Germany, France, United Kingdom, Italy, Spain, Russia, and others)
- Latin America (Brazil, Mexico, and others)
- Middle East & Africa
Asia-Pacific enjoys a leading position in the PET-CT scanner devices market owing to the increasing investments in healthcare infrastructure, rising prevalence of cancer, and increasing adoption of advanced medical imaging technologies.
Note: If you need specific information that is not currently included in the scope of the report, it will be provided as part of the customization.
About us:
IMARC Group is a global management consulting firm that helps the world’s most ambitious changemakers to create a lasting impact. The company provide a comprehensive suite of market entry and expansion services. IMARC offerings include thorough market assessment, feasibility studies, company incorporation assistance, factory setup support, regulatory approvals and licensing navigation, branding, marketing and sales strategies, competitive landscape and benchmarking analyses, pricing and cost research, and procurement research.
Contact
IMARC Group
134 N 4th St. Brooklyn, NY 11249 United States
E-mail sales@imarcgroup.com
Phone: (D) +91 120 433 0800
USA: +1-631-791-1145 | UK: +44-753-713-2163